Tag: biotechnology
AusBiotech appoints Dr James Campbell as chair
Dr James Campbell, CEO and managing director of Patrys Limited, has been appointed as chair of AusBiotech following a unanimous vote by the Board.
Australia invests in AI to enhance biomedical manufacturing
Two leading Australian innovation centres have unveiled a joint accelerator to help biomedical companies harness the power of data and artificial intelligence (AI) during Australia’s trade mission at the global BIO convention.
AusBiotech applauds launch of Medical Science Co-Investment Plan to boost biotech sector
AusBiotech has welcomed the launch of the Medical Science Co-Investment Plan, which pinpoints four primary investment areas in the medical science domain: medical devices, complex therapeutics, digital health, and sustainability.
Peanut allergy therapy receives $12M boost from Breakthrough Victoria
The Victorian Government announced a $12 million investment in Aravax, a local biotechnology firm, in a push to revolutionise peanut allergy treatment.
La Trobe University to house BioNTech’s new mRNA manufacturing facility
La Trobe University’s Melbourne campus will soon become home to a new BioNTech facility that will manufacture new investigational mRNA therapies for serious diseases like cancer.
Victoria launches new round of grants for mRNA research, startups
Biotech manufacturing startups and research teams in Victoria can now apply for grants as part of the third round of the mRNA Victoria Research Acceleration Fund.
2023 Prime Minister’s Prizes for Science celebrate excellence in quantum science, biotechnology
The 2023 Prime Minister's Prizes for Science are highlighting and celebrating Australian accomplishments in quantum science, biotechnology, and outstanding teaching, with the awardees being honoured and celebrated for their significant contributions.
Aussie biotech firm completes bisantrene cGMP API manufacturing with Indian partner
Race Oncology Limited announced that Laurus Labs, an India-based pharmaceutical manufacturer, has produced its first batch of bisantrene dihydrochloride, Race’s active pharmaceutical ingredient (API), to a standard that meets the quality specified under the ‘Code of Good Manufacturing Practice’ (cGMP).
Breakthrough Victoria invests in Atmo’s gastrointestinal disorder diagnostic technology
Breakthrough Victoria has announced that it is investing in medical technology company Atmo Biosciences and its world-first gas-sensing capsule designed to help diagnose functional gastrointestinal disorders.
Australian engineer receives global recognition for 3D printed endoscope
Dr Jiawen Li, a biomedical engineer from the University of Adelaide who developed a 3D-printed ultrathin endoscope, was named in the MIT Technology Review 2023 global list of Innovators Under 35.